A pilot study of orelabrutinib treatment in three cases of refractory/relapsed autoimmune haemolytic anaemia/Evans syndrome
British Journal of Haematology · 2024-03 · 204 (3) · 1082-1085
DOI: 10.1111/bjh.19146 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, online erschienen am 06.11.2023. Verfasst von Hui Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin Medical University General Hospital, Tianjin, P.R. China. Hauptthemen laut MEDLINE: Anemia, Hemolytic, Autoimmune, Piperidines, Pyridines, Thrombocytopenia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: Tianjin Education Commission Research Project.
Abstract (Originalsprache)
Currently, there is no effective treatment for refractory/relapsed (R/R) autoimmune haemolytic anaemia (AIHA), associated with poor quality of life. Bruton tyrosine kinase inhibitors have begun to be used in some autoimmune diseases. We initiated the clinical trial of orelabrutinib treatment on R/R AIHA/Evans Syndrome, which is in progress. The preliminary results showed that nine of the 12 enrolled patients responded to orelabrutinib treatment. Here, we reported three cases who have completed the treatment and were followed up for 6 months, achieving complete or partial remission. Orelabrutinib is expected to become a new second‐line treatment for R/R AIHA/Evans syndrome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Tianjin Medical University General Hospital, Tianjin, P.R. China.
ORCID-Profile: Hui Liu, Wei Zhang, Huaquan Wang, Rong Fu
Förderung
- Tianjin Education Commission Research Project
Zitieren
APA
Liu, H., Ding, K., Zhang, W., Xing, L., Wang, Y., Wang, H., Song, J., Li, L., & Fu, R. (2024). A pilot study of orelabrutinib treatment in three cases of refractory/relapsed autoimmune haemolytic anaemia/Evans syndrome. British Journal of Haematology, 204(3), 1082-1085. https://doi.org/10.1111/bjh.19146
Vancouver
Liu H, Ding K, Zhang W, Xing L, Wang Y, Wang H, et al. A pilot study of orelabrutinib treatment in three cases of refractory/relapsed autoimmune haemolytic anaemia/Evans syndrome. British Journal of Haematology. 2024;204(3):1082-1085. doi:10.1111/bjh.19146
BibTeX
@article{Liu2024,
author = {Liu, Hui and Ding, Kai and Zhang, Wei and Xing, Limin and Wang, Yihao and Wang, Huaquan and Song, Jia and Li, Lijuan and Fu, Rong},
title = {A pilot study of orelabrutinib treatment in three cases of refractory/relapsed autoimmune haemolytic anaemia/Evans syndrome},
journal = {British Journal of Haematology},
year = {2024},
volume = {204},
number = {3},
pages = {1082--1085},
doi = {10.1111/bjh.19146}
}
EUVIMED